MULTIPLE SCLEROSIS SOCIETY — grant history
Latest income
£29.8m
Grants listed (FY2024)
44
Listed grants total
£24.0m
Accounts grants total
£5.9m
listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2024 accounts
What this funder supports
Causes funded
- Education/training
- The Advancement Of Health Or Saving Of Lives
- Disability
Where grantees operate
- Cardiff
- City Of Swansea
- Ireland
- Northern Ireland
- Scotland
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| University of Cambridge | FY2024 | £13.0m | Prof RJM Franklin, Cambridge Centre for Myelin Repair Renewal |
| Other grants awarded and write backs | FY2024 | £2.1m | Other grants awarded and write backs |
| University College London (UCL) | FY2024 | £1.9m | Prof J Chataway, Efficient clinical trials programme |
| Imperial College London | FY2024 | £808k | Prof R Nicholas, The MS and PD Tissue Bank |
| Brunel University London | FY2024 | £723k | Dr D Bailey, iStep-MS II: a physical activity and sedentary behaviour intervention for reducing fatigue in people living with MS |
| Other grants awarded | FY2024 | £541k | Other grants awarded |
| Swansea University | FY2024 | £451k | Dr. R Middleton, UK MS Register grant |
| Other grants awarded and write backs | FY2024 | £355k | Other grants awarded and write backs |
| Queen's University, Belfast | FY2024 | £279k | Prof D Fitzgerald, Building capacity for a Multiple Sclerosis Centre of Excellence in Northern Ireland |
| Queen Mary, University of London | FY2024 | £247k | Grants awarded and write backs |
| International Progressive MS Alliance | FY2024 | £242k | Grant to the alliance |
| University of Nottingham | FY2024 | £242k | Dr C Gilmartin, Early detection of progression in MS using OPM-MEG |
| Nottingham University Hospitals Trust | FY2024 | £240k | Dr R Abdel-Fahim, GUIDE-MS: lonGitudinal evolUtion of Iron rim and expanDing lEsions in MS using ultra high field imaging at 7Tesla |
| Write backs and other grants awarded | FY2024 | £240k | Write backs and other grants awarded |
| Other grants awarded and write backs | FY2024 | £219k | Other grants awarded and write backs |
| Other grants awarded and write backs | FY2024 | £185k | Other grants awarded and write backs |
| Kings College London | FY2024 | £185k | Other grants awarded and write backs |
| University of Oxford | FY2024 | £180k | Other grants awarded and write backs |
| Prof A Coles, A phase Iia trial of the ability of the combination of metformin and clemastine to promote remyelination in people with | FY2024 | £166k | A phase Iia trial of the ability of the combination of metformin and clemastine to promote remyelination in people with |
| University of Edinburgh | FY2024 | £149k | Prof A Williams, The Edinburgh MS Centre for Translational Research |
| Leeds Teaching Hospitals NHS Trust | FY2024 | £143k | Other grants awarded and write backs |
| Other grants awarded and write backs | FY2024 | £139k | Other grants awarded and write backs |
| Northumbria University | FY2024 | £139k | Other grants awarded and write backs |
| Dr D Chard, Predicting progressive MS: a longitudinal clinical and MRI study | FY2024 | £118k | Predicting progressive MS: a longitudinal clinical and MRI study |
| Prof J Chataway, Efficient clinical trials programme | FY2024 | £110k | Efficient clinical trials programme |
| Cambridge University Hospitals | FY2024 | £102k | Other grants awarded and write backs |
| Other grants awarded and write backs | FY2024 | £94k | Other grants awarded and write backs |
| University of Liverpool | FY2024 | £86k | Other grants awarded and write backs |
| Cardiff University | FY2024 | £73k | Other grants awarded and write backs |
| University of Southampton | FY2024 | £72k | Other grants awarded and write backs |
| University of Portsmouth | FY2024 | £68k | Other grants awarded and write backs |
| University of Plymouth | FY2024 | £57k | Other grants awarded and write backs |
| University of Bristol | FY2024 | £50k | Other grants awarded and write backs |
| Versus Arthritus | FY2024 | £49k | Other grants awarded and write backs |
| University of Glasgow | FY2024 | £48k | Other grants awarded and write backs |
| University of Birmingham | FY2024 | £41k | Other grants awarded and write backs |
| University of Sheffield | FY2024 | £40k | Other grants awarded and write backs |
| Glasgow Caledonian University | FY2024 | £39k | Other grants awarded and write backs |
| University of Salford | FY2024 | £2k | Other grants awarded and write backs |
| Liverpool John Moores University | FY2024 | £1k | Other grants awarded and write backs |
| Wellcome Trust - Medical Research Council Stem Cell Insitute, Univ of Cambridge | FY2024 | £-1k | Other grants awarded and write backs |
| University of Exeter | FY2024 | £-2k | Other grants awarded and write backs |
| University of Leeds | FY2024 | £-7k | Other grants awarded and write backs |
| Leeds General infimary | FY2024 | £-13k | Other grants awarded and write backs |
| University College London (UCL) | FY2023 | £13.0m | Prof J Chataway, Efficient clinical trials programme; Prof K Smith, Understanding the haemodynamic consequences of neuroinflammatory oedema for therapeutic gain. |
| University of Edinburgh | FY2023 | £3.6m | Prof S Chandran, The Edinburgh MS Centre for Translational Research. |
| University of Cambridge | FY2023 | £2.0m | Prof RJM Franklin, Cambridge Centre for Myelin Repair Renewal; Dr M Grant-Peters, Characterising molecular features of neurodegeneration in progressive MS: an integrative meta-analysis; Prof A Coles, A phase Iia trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing MS. |
| Other sundry | FY2023 | £1.1m | Other grants awarded and write backs. |
| King's College, London | FY2023 | £744k | Prof R Moss-Morris, Digital Health Therapeutics for treating MS Symptoms. |
| International Progressive MS Alliance | FY2023 | £726k | Grant to the alliance. |
| Glasgow Caledonian University | FY2023 | £721k | Prof L Paul, Exercise/Physical Activity for Symptom and Disease Management in people moderately to severely affected with MS. |
| Queen's University, Belfast | FY2023 | £490k | Dr Y Dombrowski, Investigating inflammasomes as targets for MS; Prof D Fitzgerald, Investigating the eye as a window to brain inflammation in MS. |
| University of Nottingham | FY2023 | £348k | Dr B De Dios Perez, Optimising access to vocational rehabilitation services for people with MS through MS charities; Dr K Radford, Preventing job loss for people with MS: implementing vocational rehab in the NHS. |
| University of Glasgow | FY2023 | £330k | Prof J Edgar, Defining the role KIF21B in glia. |
| Queen Mary, University of London | FY2023 | £298k | Prof R Dobson, Pregnancy and Methylation changes in MS (PaMMS). |
| University of Cardiff | FY2023 | £293k | Dr E Tallantyre, DELIVER-MS Long-term Extension. |
| Imperial College London | FY2023 | £204k | Other grants awarded and write backs. |
| University of Salford | FY2023 | £204k | Prof A Brettle, Greater Manchester MS Information Network (GMMSIN): a locally tailored social media hub for MS self-management in newly diagnosed People Living with MS. |
| University of Plymouth | FY2023 | £130k | Other grants awarded and write backs. |
| University of Southampton | FY2023 | £129k | Other grants awarded and write backs. |
| Liverpool, John Moores University | FY2023 | £102k | Other grants awarded and write backs. |
| National Institute for Health and Care Research | FY2023 | £79k | Other grants awarded and write backs. |
| University of Birmingham | FY2023 | £73k | Other grants awarded and write backs. |
| University of Manchester | FY2023 | £68k | Other grants awarded and write backs. |
| Leeds Teaching Hospitals NHS Trust | FY2023 | £48k | Other grants awarded and write backs. |
| Oxford Brookes University | FY2023 | £38k | Other grants awarded and write backs. |
| Versus Arthritus | FY2023 | £34k | Other grants awarded and write backs. |
| University of Portsmouth | FY2023 | £27k | Other grants awarded and write backs. |
| Swansea University | FY2023 | £15k | Other grants awarded and write backs. |
| Oxford University | FY2023 | £6k | Other grants awarded and write backs. |
| International Progressive MS Alliance | FY2022 | £13.0m | Grant to the alliance |
| University College London (UCL) | FY2022 | £3.7m | Prof J Chataway, Efficient clinical trials programme; Prof J Chataway, MS-STAT2 MRI; Other grants awarded and write backs |
| Imperial College London | FY2022 | £2.0m | Prof R Nicholas, The MS and Parkinson's Disease Tissue Bank grants; Other grants awarded and write backs |
| Swansea University | FY2022 | £381k | Prof David Ford, UK MS Register grants; Other grants awarded and write backs |
| University of Cambridge | FY2022 | £309k | Prof RJM Franklin, Cambridge Centre for Myelin Repair Renewal; Other grants awarded and write backs |
| University of Glasgow | FY2022 | £268k | Dr J Edgar, Novel cellular models to study oligodendrocyte-mediated axonal support; Write backs and other grants awarded |
| Leeds Teaching Hospitals NHS Trust | FY2022 | £255k | Dr C Wicks, Assessing NHS ImplemeNTation of an onlinE Resilience-training Acceptance and Commitment Therapy (ACT) programme to prevent job loss in MS (INTER-ACT MS) |
| University of Oxford | FY2022 | £204k | Prof G DeLuca, Molecular mechanisms of neurodegeneration in progressive multiple sclerosis; Other grants |
| University of Manchester | FY2022 | £142k | Dr E Doman, Mathematical models of MS medications in the placenta |
| Queen Mary, University of London | FY2022 | £132k | Dr A Thomson, Participatory Research into Minoritised Patient Experiences of MS; Care; Other grants awarded and write backs |
| University of Portsmouth | FY2022 | £129k | Other grants awarded |
| University of Southampton | FY2022 | £125k | Other grants awarded |
| King's College, London | FY2022 | £99k | Dr J Hudson, Identifying and treating psychological distress in response to MS: Testing COMPASS-MS – a therapist supported digital treatment for anxiety and depression (distress) in MS in routine care; Write backs and other grants awarded |
| University of Edinburgh | FY2022 | £81k | Prof S Chandran, The Edinburgh MS Centre for Translational Research; Other grants awarded and write backs |
| University of Nottingham | FY2022 | £72k | Dr N Evangelou, Determining the Effectiveness of Early Intensive Versus Escalation approaches for the treatment of relapsing-remitting MS; Dr R Dineen, A Feasibility Trial of Neuromodulation with Connectivity-Guided Intermittent Theta Burst Stimulation for Cognitive Impairment in MS; Write backs and other grants awarded |
| Oxford Brookes University | FY2022 | £69k | Other grants awarded |
| National Institute for Health and Care Research | FY2022 | £63k | Prof R Moss-Morris, Developing, optimising and implementing a blended digital self-management tReatmEnt for FatigUe in multiplE scLerosis (REFUEL-MS) |
| Versus Arthritus | FY2022 | £60k | Other grants awarded |
| University of Birmingham | FY2022 | £28k | Dr C Shannon-Lowe, Understanding how Epstein Barr virus promotes the development of Multiple Sclerosis |
| International Progressive MS Alliance | FY2021 | £1.2m | Grant to the alliance |
| University of Cambridge | FY2021 | £1.0m | Cambridge Centre for Myelin Repair Renewal |
| University College London (UCL) | FY2021 | £1.0m | Efficient clinical trials programme |
| University College London (UCL) | FY2021 | £136k | MS-STAT2 MRI |
| University of Cambridge | FY2021 | £136k | A phase Iia trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing MS |
| University College London (UCL) | FY2021 | £126k | Assessing treatment responses using machine learning |
| University of Cambridge | FY2021 | £126k | Write back of old Myelin Repair Renewal grant |
| Queen Mary, University of London | FY2021 | £100k | GloBody monitoring for effective MS treatment |
| University College London (UCL) | FY2021 | £100k | Understanding the haemodynamic consequences of neuroinflammatory oedema for therapeutic gain |
| University College London (UCL) | FY2021 | £100k | Silent MRI for monitoring MS |
| University of Cambridge | FY2021 | £100k | Imaging remyelination in the central nervous system |
| University of Edinburgh | FY2021 | £100k | The Edinburgh MS Centre for Translational Research |
| University of Edinburgh | FY2021 | £100k | Peripheral monocytes for central nervous system remyelination |
| Association of British Neurologists | FY2021 | £100k | Using MRI and serum biomarkers to understand accumulation of disability in paediatric multiple sclerosis |
| University of Nottingham | FY2021 | £100k | Determining the Effectiveness of Early Intensive Versus Escalation approaches for the treatment of relapsing-remitting MS |
| University of Nottingham | FY2021 | £100k | A Feasibility Trial of Neuromodulation with Connectivity-Guided Intermittent Theta Burst Stimulation for Cognitive Impairment in MS |
| University of Nottingham | FY2021 | £100k | Preventing job loss for people with MS: implementing vocational rehab in the NHS |
| University of Glasgow | FY2021 | £100k | Novel cellular models to study oligodendrocyte-mediated axonal support |
| Imperial College London | FY2021 | £100k | The MS and Parkinson's Disease Tissue Bank grants |
| Imperial College London | FY2021 | £100k | Optimising vascular risk calculators in people with multiple sclerosis as tools to impact disability progression |
| University of Oxford | FY2021 | £100k | Molecular mechanisms of neurodegeneration in progressive multiple sclerosis |
| University of Oxford | FY2021 | £100k | The role of Nurr1 in the interplay of inflammation and neurodegeneration in multiple sclerosis |
| UKRI Medical Research Council | FY2021 | £71k | Genomic determinants of MS susceptibility in an ethnically diverse population |
| Leeds General Infirmary | FY2021 | £64k | MS-PROACTIVE: Preventing job loss using Acceptance & Commitment Therapy in Vocational Rehabilitation- an ext randomised pilot trial |
| University of Cambridge | FY2021 | £56k | ROS signalling and CNS remyelination |
| University College London (UCL) | FY2021 | £56k | Predicting progressive MS: a longitudinal clinical and MRI study |
| Swansea University | FY2021 | £54k | UK MS Register grants |